tradingkey.logo
tradingkey.logo
Search

Atea Pharmaceuticals Inc

AVIR
Add to Watchlist
5.310USD
+0.130+2.51%
Close 09-11 16:00ET
426.69MMarket Cap
LossP/E TTM

AVIR Financials

See Atea Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
426.69M
Dividend TTM
0.00
P/E TTM
-2.52
EPS TTM
-2.11
Revenue
--
Net Profit
-168.38M
ROE
-52.58%
ROA
-47.95%

Atea Pharmaceuticals Inc Earnings Date

Latest Release
Aug 12, 2026
EPS / Forecast
-0.41/-0.56
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
7.29%-0.41
-42.56%-0.57
-44.64%-0.57
-44.15%-0.53
7.74%-0.44
46.54%-0.40
15.39%-0.40
7.15%-0.37
-42.32%-0.48
-76.87%-0.75
-13.54%-0.47
---0.40
---0.34
---0.43
---0.41
---0.98
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
295.16%192.18M
--32.81M
Net Profit
11.38%-32.93M
-32.59%-45.44M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-129.40%-34.43M
71.39%-8.07M
-2136.06%-31.34M
-237.00%-42.08M
467.06%117.13M
-59.99%-28.19M
Debt to assets ratio
----
----
----
----
----
----
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
295.16%192.18M
--32.81M
Operating profit
15.27%-35.10M
-26.98%-48.01M
-55.14%-54.71M
-46.79%-45.45M
-16.92%-41.42M
-23.74%-37.81M
-24.40%-35.27M
-0.99%-30.97M
-20.89%-35.43M
6.33%-30.55M
-4.70%-28.35M
-15.60%-30.66M
-2.26%-29.31M
-13.09%-32.62M
-119.45%-27.08M
-516.52%-26.52M
-176.37%-28.66M
-159.15%-28.84M
363.90%139.22M
167.48%6.37M
Net Profit
11.38%-32.93M
-32.59%-45.44M
-33.76%-44.87M
-34.98%-42.05M
8.29%-37.16M
45.75%-34.27M
14.35%-33.54M
6.01%-31.15M
-43.78%-40.52M
-78.11%-63.17M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-129.40%-34.43M
71.39%-8.07M
-2136.06%-31.34M
-237.00%-42.08M
467.06%117.13M
-59.99%-28.19M
Current assets
-40.70%228.66M
-39.31%263.20M
-32.74%310.99M
-30.96%336.14M
-23.85%385.60M
-20.97%433.71M
-21.70%462.36M
-19.30%486.91M
-18.44%506.37M
-13.22%548.76M
-10.66%590.46M
-11.53%603.32M
-9.95%620.83M
-11.33%632.39M
-14.43%660.92M
-19.10%681.93M
-20.85%689.45M
-15.11%713.23M
-10.55%772.40M
677.53%842.95M
Total current liabilities
39.79%28.12M
53.43%33.37M
113.86%39.78M
-19.91%20.18M
-24.42%20.12M
-47.36%21.75M
-42.54%18.60M
33.33%25.19M
64.73%26.62M
234.20%41.31M
75.21%32.38M
20.85%18.89M
-35.64%16.16M
-56.79%12.36M
-67.52%18.48M
-94.03%15.63M
-90.83%25.11M
-88.75%28.61M
-81.99%56.88M
2322.82%262.05M
Total assets
-40.68%232.28M
-39.30%267.08M
-32.16%315.22M
-30.14%342.96M
-23.27%391.61M
-20.44%439.96M
-21.90%464.67M
-19.26%490.96M
-18.47%510.38M
-13.34%553.03M
-10.76%594.97M
-11.43%608.08M
-9.84%626.03M
-11.02%638.13M
-13.74%666.71M
-18.60%686.58M
-20.33%694.34M
-14.69%717.19M
-10.51%772.89M
666.08%843.50M
Total liabilities
3.44%28.12M
15.54%33.37M
54.20%39.78M
-16.19%27.18M
-19.83%27.19M
-40.65%28.88M
-35.13%25.80M
23.12%32.44M
43.22%33.91M
143.91%48.66M
52.19%39.78M
12.64%26.34M
-30.11%23.68M
-46.52%19.95M
-58.39%26.14M
-91.07%23.39M
-87.62%33.88M
-85.34%37.30M
-80.11%62.81M
2310.34%262.05M
Total equity
-43.98%204.16M
-43.15%233.71M
-37.24%275.43M
-31.13%315.78M
-23.52%364.42M
-18.50%411.08M
-20.95%438.87M
-21.18%458.52M
-20.90%476.47M
-18.41%504.37M
-13.33%555.19M
-12.28%581.73M
-8.80%602.35M
-9.08%618.18M
-9.79%640.57M
14.06%663.19M
10.47%660.46M
15.97%679.88M
29.62%710.08M
485.94%581.45M
Net operating income
-12.82%-37.08M
-51.79%-46.39M
7.15%-28.22M
-75.28%-40.38M
22.11%-32.87M
23.33%-30.56M
-39.22%-30.40M
-30.95%-23.04M
-161.80%-42.20M
-33.55%-39.87M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
-250.47%-59.01M
-123.68%-75.42M
338.40%22.60M
Net investment
124.43%34.31M
-65.26%29.74M
1482.55%46.59M
133.85%41.30M
-87.74%15.29M
50.71%85.61M
-112.13%-3.37M
-108.52%-122.01M
167.77%124.69M
132.03%56.80M
-17.07%27.77M
87.98%-58.51M
2578.18%46.56M
55736.36%24.48M
837300.00%33.49M
---486.98M
---1.88M
---44.00K
20.00%-4.00K
100.00%0.00
Net financing
100.00%0.00
174.06%257.00K
--0.00
-9762.39%-11.30M
---14.09M
-331.33%-347.00K
--0.00
27.17%117.00K
--0.00
-9.09%150.00K
--0.00
-37.41%92.00K
--0.00
-26.01%165.00K
-100.00%0.00
-81.51%147.00K
-100.00%0.00
-52.65%223.00K
-99.97%142.00K
187.08%795.00K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its current assets were 310.99M, with a year-on-year change of -32.74.

What are the total assets of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its total assets of Atea Pharmaceuticals Inc were 315.22M, with a year-on-year change of -32.16.

What are the total liabilities of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Atea Pharmaceuticals Inc were 39.78M, with a year-on-year change of 54.20.

What is the total equity of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its total equity of Atea Pharmaceuticals Inc was 275.43M, with a year-on-year change of -37.24.

What is the net operating income of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Atea Pharmaceuticals Inc was -179.40M, with a year-on-year change of -35.68.

What is the net investment of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its net investment of Atea Pharmaceuticals Inc was 188.79M, with a year-on-year change of 236.50.

What is the net financing of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its net financing of Atea Pharmaceuticals Inc was -25.75M, with a year-on-year change of -9742.32.

What is the Earnings Per Share (EPS) of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.94, with a year-on-year change of 2.76.

What is the net income of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its net income was -158.35M, with a year-on-year change of 5.96.

What is the Return on Equity (ROE) of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -44.34, with a year-on-year change of -30.87.

What is the Return on Assets (ROA) of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -40.61, with a year-on-year change of -27.77.

What is the operating profit of Atea Pharmaceuticals Inc?

According to Atea Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -179.40M, with a year-on-year change of -35.68.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.